Envoy Medical, Inc. (COCH)
NASDAQ: COCH · Real-Time Price · USD
0.7470
+0.0008 (0.11%)
Aug 25, 2026, 4:00 PM EDT - Market closed
Envoy Medical Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, Envoy Medical stock has a consensus rating of "Strong Buy" and an average price target of $2.25. The average 1-year stock price forecast is 201.20% higher than the current stock price, while the lowest is $2.00 (+167.74%) and the highest is $2.50 (+234.67%).
Price Target: $2.25 (+201.20%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Envoy Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Mar '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 2 | 1 | 1 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 2 | 1 | 1 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $2.5 → $2 | Buy | Reiterates | $2.5 → $2 | +167.74% | Aug 21, 2026 |
| Lucid Capital | Lucid Capital | Buy Initiates $2 | Buy | Initiates | $2 | +167.74% | Jul 27, 2026 |
Financial Forecast
Revenue This Year
250.00K
from 241.00K
Increased by 3.73%
Revenue Next Year
310.00K
from 250.00K
Increased by 24.00%
EPS This Year
-0.30
from -1.23
EPS Next Year
-0.22
from -0.30
EPS and Forward PE are based on non-GAAP adjusted numbers.